No Prescription |
 |
 | ||
|
Selsun Treatment Genertic Selenium Sulphide |
|
| ||
No Prescription » Prescription Drugs 14 » Selsun Treatment Genertic Selenium Sulphide Selsun Treatment is used to treat dandruff as well as conditions involving seborrhoeic dermatitis tinea versicolor dandruff and as an adjunct in the treatment of tinea capitis." Features Medically proven. Usage Directions: - Shake bottle well1. Scalp Treatment - Apply Selsun to wet hair lather and leave on scalp for 3 minutes. Rinse. Repeat treatment then rinse thoroughly in running water. Use twice weekly at first then as necessary or as physician directs.2. Skin Treatment- Apply undiluted to affected areas for 10 minutes. Rinse thoroughly. Repeat daily for 1 week or as physician directs. Ingredients Selenium sulfide Warning Keep out of reach of children. Do not swallow. Avoid contact with eyes. Avoid use 48 hours before of after permanent waving tinting or bleeching. Do not use on severely inflamed skin. If irritation occurs discontinue use. Avoid contact with jewellry.First Aid - If poisoning occurs contact a doctor or poisons information centre. If swallowed and more than 15 minutes from a hospital induce vomiting preferably using ipecac syrup APF. Store below 30 degrees C. Buy Selsun Treatment Genertic Selenium Sulphide and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About Selsun Treatment Genertic Selenium Sulphide: Product Type: Prescription Drugs 14 Selsun Treatment ( Genertic Selenium Sulphide ) - Prodcut Origin: New Zealand Selsun Treatment (Genertic Selenium Sulphide) Genertic Selenium Sulphide 2.50% Genertic Selenium Sulphide Selsun Treatment
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
